Home › Treatment-Resistant Depressive Disorder
Pag-aaral pangklinika para sa Treatment-Resistant Depressive Disorder na nagre-recruit sa U.S.
33 pag-aaral para sa Treatment-Resistant Depressive Disorder ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- San Diego, CA9 pag-aaral
- New York City, NY7 pag-aaral
- Houston, TX6 pag-aaral
- St. Louis, MO6 pag-aaral
- Austin, TX4 pag-aaral
- Dallas, TX4 pag-aaral
- Boston, MA3 pag-aaral
- Minneapolis, MN3 pag-aaral
- Columbus, OH3 pag-aaral
- Orlando, FL3 pag-aaral
- Atlanta, GA3 pag-aaral
- Salt Lake City, UT3 pag-aaral
- Los Angeles, CA3 pag-aaral
- Tampa, FL3 pag-aaral
- Sandy Springs, GA3 pag-aaral
- Rochester, MN3 pag-aaral
- Washington, DC3 pag-aaral
- Queens, NY3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- California12 pag-aaral
- Florida6 pag-aaral
- Georgia5 pag-aaral
- Illinois4 pag-aaral
- Maryland5 pag-aaral
- Massachusetts8 pag-aaral
- Minnesota5 pag-aaral
- Missouri7 pag-aaral
- New York10 pag-aaral
- Ohio5 pag-aaral
- South Carolina3 pag-aaral
- Texas8 pag-aaral
- Utah3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
DBS for Depression
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06096207Natural History of Depression, Bipolar Disorder and Suicide Risk
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06462196Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Nagre-recruit
Edad 22 hanggang 85 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07594483Biomarker-Guided Antidepressant Selection
Nagre-recruitPhase 4
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07680140ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07284667A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT03887715EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
Nagre-recruit
Edad 22 hanggang 60 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07862205A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07716098SAINT® Therapy for Memory Problems in Older Adults With Treatment-Resistant Depression
Nagre-recruit
Edad 65 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07876908ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07553637A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
Nagre-recruitPhase 2/3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07227103Intravenous Ketamine for Treatment-Resistant Depression
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT06668571Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Nagre-recruit
Edad 22 hanggang 70 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT06423430Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06511908Long-term Observation of Participants With Mood Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT04877977DBS for TRD With the Medtronic Percept PC
Nagre-recruit
Edad 25 hanggang 70 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05773755Lumateperone for Late-Life Depression
Nagre-recruitPhase 3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07623135Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 21 hanggang 45 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06480201Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07217223One-Day cTBS Over the Precuneus
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07758010PCS in Severe Treatment Resistant Depression
Nagre-recruit
Edad 22 hanggang 70 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04124341Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT07563868Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression
Nagre-recruit
Edad 21 hanggang 70 · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT03952962Mindfulness Engaged Neurostimulation for Depression (MEND II)
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 6, 2026 · NCT07512284Maintenance rTMS for Depression (Maitr-De)
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT06938841Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.